These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32448620)

  • 1. A unique algorithm for the determination of peptide-carrier protein conjugation ratio by amino acid analysis using intrinsic internal standard.
    Yang GJ; Yang Y; Shaddeau A; Cai CX; Li Y; Gulla K; Zhang Y; Ou L; Cooper JW; Lei QP
    Vaccine; 2020 Jun; 38(29):4507-4511. PubMed ID: 32448620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen.
    Ou L; Kong WP; Chuang GY; Ghosh M; Gulla K; O'Dell S; Varriale J; Barefoot N; Changela A; Chao CW; Cheng C; Druz A; Kong R; McKee K; Rawi R; Sarfo EK; Schön A; Shaddeau A; Tsybovsky Y; Verardi R; Wang S; Wanninger TG; Xu K; Yang GJ; Zhang B; Zhang Y; Zhou T; ; Arnold FJ; Doria-Rose NA; Lei QP; Ryan ET; Vann WF; Mascola JR; Kwong PD
    Sci Rep; 2020 Feb; 10(1):3032. PubMed ID: 32080235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1.
    Ou L; Gulla K; Biju A; Biner DW; Bylund T; Changela A; Chen SJ; Zheng CY; Cibelli N; Corrigan AR; Duan H; Gonelli CA; Kong WP; Cheng C; O'Dell S; Sarfo EK; Shaddeau A; Wang S; Vinitsky A; Yang Y; Zhang B; Zhang Y; Koup RA; Doria-Rose NA; Gall JG; Mascola JR; Kwong PD
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streamlining Peptide Mapping LC-MS Approach for Studying Fusion Peptide-Conjugated Vaccine Immunogens.
    Ivleva VB; Gowetski DB; Lei QP
    J Am Soc Mass Spectrom; 2021 Dec; 32(12):2777-2790. PubMed ID: 34751576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Cysteine Modifications in Recombinant Protein Tetanus Toxoid Heavy Chain Fragment C.
    Cai CX; Schneck NA; Cozine T; Ivleva VB; Ragheb D; Gollapudi D; Patel A; Barefoot N; Gowetski DB; Lei QP
    J Am Soc Mass Spectrom; 2021 Jul; 32(7):1837-1840. PubMed ID: 34167299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of degradation for sulfo-SIAB, SM(PEG)
    Resto M; Vinitsky A; Schneck NA; Wolff JJ; Shajahan A; Cibelli N; Zhang Y; Li Y; Gulla K; Gowetski DB; Gall JG; Lei QP
    J Pharm Biomed Anal; 2024 Dec; 251():116455. PubMed ID: 39232447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internally standardized amino acid analysis for determining peptide/carrier protein coupling ratio.
    Tsao JL; Lin X; Lackland H; Tous G; Wu YL; Stein S
    Anal Biochem; 1991 Aug; 197(1):137-42. PubMed ID: 1952056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different hapten-carrier conjugation ratios and molecular orientations on antibody affinity against a peptide antigen.
    Pedersen MK; Sorensen NS; Heegaard PM; Beyer NH; Bruun L
    J Immunol Methods; 2006 Apr; 311(1-2):198-206. PubMed ID: 16574142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of residual hydrophobic fusion peptide with monomer and dimer forms using reversed-phase liquid chromatography.
    Cai CX; Schneck NA; Ivleva VB; Gulla K; Zhang Y; Gowetski D; Paula Lei Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1144():122073. PubMed ID: 32224438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.
    Baruffaldi F; Kelcher AH; Laudenbach M; Gradinati V; Limkar A; Roslawski M; Birnbaum A; Lees A; Hassler C; Runyon S; Pravetoni M
    Mol Pharm; 2018 Nov; 15(11):4947-4962. PubMed ID: 30240216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation of synthetic peptides to carrier iscoms: factors affecting the immunogenicity of the conjugate.
    Lövgren K; Larsson M
    J Immunol Methods; 1994 Aug; 173(2):237-43. PubMed ID: 7519222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens.
    Pütz MM; Ammerlaan W; Schneider F; Jung G; Muller CP
    Vaccine; 2004 Oct; 22(31-32):4173-82. PubMed ID: 15474707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of anti-malaria antibodies with a way of peptide-protein conjugation].
    Qian F
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Dec; 30(6):442-5. PubMed ID: 23484254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immunogenicity and cross-reactivity of HIV-1 V3-peptide and multiple antigen peptides conjugated to distinct carrier proteins.
    Cruz LJ; Cabrales A; Iglesias E; Aguilar JC; González LJ; Reyes O
    Int Immunopharmacol; 2009 Nov; 9(12):1452-9. PubMed ID: 19747570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
    Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
    Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel chemical approach to drug delivery: lipidic amino acid conjugates.
    Toth I
    J Drug Target; 1994; 2(3):217-39. PubMed ID: 7812692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines.
    Lockyer K; Gao F; Derrick JP; Bolgiano B
    Vaccine; 2015 Mar; 33(11):1345-52. PubMed ID: 25640334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody.
    Li L; Olafsen T; Anderson AL; Wu A; Raubitschek AA; Shively JE
    Bioconjug Chem; 2002; 13(5):985-95. PubMed ID: 12236780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of antifungal vaccines by conjugation of β-1,2 trimannosides with T-cell peptides and covalent anchoring of neoglycopeptide to tetanus toxoid.
    Cartmell J; Paszkiewicz E; Dziadek S; Tam PH; Luu T; Sarkar S; Lipinski T; Bundle DR
    Carbohydr Res; 2015 Feb; 403():123-34. PubMed ID: 25126994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.